Welcome to the 2024 Annual Meeting of Stockholders for Intellia Therapeutics, Inc. Our host for today is Dr. Frank Verwiel, Chairperson of the Board of Intellia Therapeutics, Inc. At this time, all participants will be in a listen-only mode. I will now turn the call over to your host. Dr. Verwiel, you may begin. Hello, Dr. Verwiel, you may begin. Oh, and it appears that his line's disconnected. One moment while we reconnect him. And Dr. Verwiel, you may begin.
Okay. Thank you very much. Good morning. I'm Dr. Frank Verwiel, Chairperson of the Board of Intellia Therapeutics, Inc., and I will act as Chairperson of this meeting. I am pleased to welcome you to the Intellia 2024 Annual Meeting of Stockholders. Before I call the meeting to order, I would like to introduce you to the members of our board and our executive team who are with us today. The other members of the board with us today are Muna Bhanji, Bill Chase, Dr. Fred Cohen, Dr. Jesse Goodman, Dr. Georgia Keresty, and Dr. John Leonard, our President and Chief Executive Officer.
The other officers and members of management of the company with us today are Jim Basta, General Counsel and Corporate Secretary; Dr. Eliana Clark, Chief Technology Officer; Glenn Goddard, Chief Financial Officer; Derek Hicks, Chief Business Officer; Dr. David Lebwohl, Chief Medical Officer; Dr.
Laura Sepp-Lorenzino, Chief Scientific Officer, Mike Dube, Chief Accounting Officer, and Dan Lepp, Associate General Counsel. Mr. Basta will act as Secretary, and Mr. Lepp will act as Inspector of Elections for this meeting. Mr. Lepp has taken and subscribed to the customary oath of office to execute his duties with strict impartiality, which will be filed with the records of the meeting. I also would like to introduce Jane Holmes of the Deloitte & Touche.
Morning, Stockholders. Are you there, Frank?
Yes, I'm here.
Okay. Let's start from the top.
Okay. Good morning. I'm Dr. Frank Verwiel, Chairperson of the Board of Intellia Therapeutics, Inc., and I will act as Chairperson of this meeting. I am pleased to welcome you to the Intellia 2024 Annual Meeting of Stockholders. Before I call the meeting to order, I would like to introduce you to the members of our board and our executive team who are with us today. The other members of the board with us today are Muna Bhanji, Bill Chase, Dr. Fred Cohen, Dr. Jesse Goodman, Dr. Georgia Keresty, and Dr. John Leonard, our President and Chief Executive Officer.
The other officers and members of management of the company with us today are James Basta, General Counsel and Corporate Secretary; Dr. Eliana Clark, Chief Technology Officer; Glenn Goddard, Chief Financial Officer; Derek Hicks, Chief Business Officer; Dr. David Lebwohl, Chief Medical Officer; Dr.
Laura Sepp-Lorenzino, Chief Scientific Officer; Mike Dube, Chief Accounting Officer; and Dan Lepp, Associate General Counsel. Mr. Basta will act as Secretary, and Mr. Lepp will act as the Inspector of Elections for this meeting. Mr. Lepp has taken and subscribed to the customary oath of office to execute his duties with strict impartiality, which will be filed with the records of this meeting. I also would like to introduce Jane Holmes of the Deloitte & Touche LLP, the company's independent registered public accounting firm who's available to respond to appropriate questions. The meeting will now officially come to order. We propose to proceed with the formal business of the meeting as set forth in the company 2024 Notice of Annual Meeting and Proxy Statement.
We request that if you have questions, please submit them following the instructions provided on the virtual meeting screen and described in the Rules of Conduct. Will the Secretary please report at this time on the mailing of the notice for this meeting and the stockholders' list?
Thank you. I have at this meeting a complete list of the stockholders of record of the company at the close of business on April 15th, 2024, the record date for this meeting. I also have an affidavit certifying that commencing on April 29th, 2024, the Notice of Internet Availability of Proxy Materials was deposited in the United States Mail to all stockholders of record as of April 15th, 2024.
Thank you. Will the Secretary please report at this time with respect to the existence of a quorum?
I have been informed by the Inspector of Elections that proxies have been received for 83,889,189 of the 96,438,608 shares of common stock outstanding on the record date, which represents approximately 87% of the total number of shares entitled to vote at this meeting. This constitutes a quorum for the meeting today, and we may now carry out the official business of the meeting. Are there any additional proxies to be submitted to the Inspector of Elections at this time? Dr. Verwiel, there have been no additional proxies submitted to me at this time.
Thank you. We will now proceed with the formal business of this meeting. The following proposals are to be considered by our stockholders at this meeting. Proposal one is the election of directors. Election of the following individuals nominated to serve as Class II directors for a three-year term ending at the annual meeting of stockholders to be held in 2027: Dr. Fred Cohen and Dr. Frank Verwiel. Proposal two is the ratification of the appointment of Deloitte & Touche LLP as the independent registered public accounting firm of the company for the fiscal year ending December 31st, 2024. Proposal three is the approval of a non-binding advisory basis of the compensation of the named executive officers.
Proposal four is the approval of a second amendment to our Second Amended and Restated Certificate of Incorporation as amended to limit the liability of certain officers of the company as permitted by recent amendments to the Delaware General Corporation Law. Those were the final proposals for today's meeting. The Secretary will now describe the voting procedure.
The time is now 9:10 A.M. Eastern Time on Wednesday, June 12th, 2024, and the polls are now open for voting on the proposals described by the Chairperson. All Intellia stockholders entitled to vote at this meeting have the ability to do so online. You do not need to vote again if you've already voted your proxy online, by telephone or by mail, and do not wish to change your vote. However, if you have either not voted already or if you want to change your previous vote, you may do so now in accordance with the instructions on your virtual meeting screen and described in the Rules of Conduct. We will now wait. The time is now 9:11 A.M. Eastern Time, and the polls are now closed for voting. May we have the results?
May we have the results of the voting, please?
Report of the Inspector of Elections covering the proposals presented at this meeting is as follows: Proposal one for the election of the following individuals, Dr. Fred Cohen and Dr. Frank Verwiel, as Class II Directors of the company is carried. Proposal two for the ratification of the appointment of Deloitte & Touche LLP as the independent registered public accounting firm of the company for the fiscal year ending December 31st, 2024, has been approved. Proposal three for the approval on a non-binding advisory basis of the compensation of the named executive officers has been approved.
Proposal four for the approval of a second amendment to our second amended and restated certificate of incorporation amended to reflect a limit of liability of certain officers of the company as permitted by recent amendments to the Delaware General Corporation Law has been approved.
Thank you. There being no other business to properly come before this meeting, let us pause for a moment to compile any questions that have been submitted via the online portal regarding only the matters that have been discussed in this formal portion of the annual meeting.
We have no further questions appropriately related to the purpose of the meeting.
There being no other business to properly come before this meeting, this meeting is now adjourned. Thank you for attending Intellia Therapeutics 2024 Annual Meeting of Stockholders.
This now concludes the meeting. Thank you for joining, and have a pleasant day.